Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems

被引:7
|
作者
Kweon, Ye-Na [1 ]
Ko, Hae-Jin [2 ]
Kim, A-Sol [2 ,3 ]
Choi, Hye-In [1 ]
Song, Ji-Eun [3 ]
Park, Ji-Yeon [1 ]
Kim, Sung-Min [3 ]
Hong, Hee-Eun [1 ]
Min, Kyung-Jin [3 ]
机构
[1] Kyungpook Natl Univ Hosp, Dept Family Med, Daegu 41944, South Korea
[2] Kyungpook Natl Univ, Sch Med, Dept Family Med, Daegu 41944, South Korea
[3] Kyungpook Natl Univ, Dept Family Med, Chilgok Hosp, Daegu 41404, South Korea
关键词
nonalcoholic fatty liver disease; Fatty Liver Index; Hepatic Steatosis Index; Simple NAFLD Score; comprehensive NAFLD Score; Framingham Risk Score; METABOLIC SYNDROME; HEPATIC STEATOSIS; OBESITY;
D O I
10.3390/healthcare9070899
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study aimed to determine whether nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for CVD and to identify the most useful NAFLD diagnostic tool for predicting CVD. Data from a total of 23,376 Korean adults without established CVD were analyzed. Cardiovascular risk was calculated using the Framingham Risk Score (FRS) 2008. The presence of NAFLD was defined as moderate-to-severe fatty liver disease diagnosed by ultrasonography. Scores for fatty liver were calculated using four NAFLD scoring systems (Fatty Liver Index, FLI; Hepatic Steatosis Index, HSI; Simple NAFLD Score, SNS; Comprehensive NAFLD Score, CNS), and were compared and analyzed according to cardiovascular risk group. Using the FRS, 67.4% of participants were considered to be at low risk of CVD, 21.5% at intermediate risk, and 11.1% at high risk. As the risk of CVD increased, both the prevalence of NAFLD and the score from each NAFLD scoring system increased significantly (p < 0.001). In the unadjusted analysis, the CNS had the strongest association with high CVD risk; in the adjusted analysis, the FLI score was most strongly associated with high CVD risk. Fatty liver is an important independent risk factor for CVD. Therefore, the available NAFLD scoring systems could be utilized to predict CVD.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Nonalcoholic fatty liver disease and cardiovascular risk in severely obese adolescents
    Sert, Ahmet
    ACTA DIABETOLOGICA, 2021, 58 (01) : 121 - 122
  • [42] Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk
    Pacifico, Lucia
    Nobili, Valerio
    Anania, Caterina
    Verdecchia, Paola
    Chiesa, Claudio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (26) : 3082 - 3091
  • [43] Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
    Alkhouri, Naim
    Carter-Kent, Christine
    Elias, Michael
    Feldstein, Ariel E.
    CLINICAL LIPIDOLOGY, 2011, 6 (03) : 305 - 314
  • [44] Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease
    Smiyan, S. I.
    Danchak, S. V.
    PATHOLOGIA, 2015, (03): : 36 - 40
  • [45] Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
    Villanova, N
    Moscatiello, S
    Ramilli, S
    Bugianesi, E
    Magalotti, D
    Vanni, E
    Zoli, M
    Marchesini, G
    HEPATOLOGY, 2005, 42 (02) : 473 - 480
  • [46] Nonalcoholic fatty liver disease is a potential risk factor for cardiovascular diseases
    Tao, H.
    Shi, K. -H.
    Wu, J. -X.
    Zhan, H. -Y.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (03) : E11 - E12
  • [47] The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
    Yayla, Cagri
    Yayla, Kadriye Gayretli
    Karanfil, Mustafa
    Ertem, Ahmet Goktug
    Unal, Sefa
    Erdol, Mehmet Akif
    Demirtas, Koray
    Akdi, Ahmet
    Coteli, Cem
    Ozilhan, Murat Oguz
    Karaaslan, Ozge Cakmak
    ANGIOLOGY, 2020, 71 (01) : 87 - 87
  • [48] Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Bisaccia, Giandomenico
    Ricci, Fabrizio
    Mantini, Cesare
    Tana, Claudio
    Romani, Gian Luca
    Schiavone, Cosima
    Gallina, Sabina
    SAGE OPEN MEDICINE, 2020, 8
  • [49] Cardiovascular risk in patients with nonalcoholic fatty liver disease: looking at the liver to shield the heart
    Cusi, Kenneth
    Godinez Leiva, Eddison
    CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (06) : 364 - 366
  • [50] Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Stal, Per
    Hultcrantz, Rolf
    Kechagias, Stergios
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1148 - +